ELDN
Eledon Pharmaceuticals Inc
2.70$
-1.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11.1% | +110.0% | +419.0% | +56.9% | -87.1% | -50.0% | +1,554.5% | +0.5% | +6.6% | +91.3% | +0.3% | -4.0% | -12.8% | |
| – | +13.3% | +785.7% | +37.6% | +3.5% | -80.7% | +166.5% | -15.2% | +142.4% | +149.3% | +3.2% | -19.7% | +100.5% | -20.4% | |
| – | – | – | – | – | -9.9% | +145.7% | +105.8% | +139.2% | -26.9% | – | – | – | – | |
| – | -99.0% | +20,300.0% | +392.2% | -307.6% | – | – | -294.7% | – | – | – | -307.6% | – | -12.1% | |
| – | +187.5% | +8.7% | +2,160.0% | -97.0% | -100.0% | – | – | – | – | – | – | – | – | |
| – | +562.5% | +230.2% | +23,048.6% | – | -34.8% | -52.6% | +0.0% | +0.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +89.5% | +166.4% | -99.5% | -92.8% | +21,167.6% | -3.9% | +28.0% | +1,032.5% | -100.4% | – | +0.0% | +304.4% | -59.7% | |
| – | +112.6% | +266.4% | -210.5% | – | – | -126.8% | – | – | -127.9% | – | – | – | -85.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.